The global breast biopsy devices market is primed for extraordinary growth, anticipated to achieve a Compound Annual Growth Rate (CAGR) of approximately 5.5% from 2022 to 2032. According to the latest forecast by Future Market Insights (FMI), the market value is poised to soar to USD 3.6 billion by 2032, marking a substantial surge from its valuation of USD 2.1 billion in 2022.
The recent report from Future Market Insights highlights the pivotal role of biopsy needle segments, with projections indicating their dominance, constituting approximately 23.4% of the global market in 2021. This upward trajectory underscores the escalating demand and significance of breast biopsy devices in the healthcare sector.
Get your PDF Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1496
Commenting on the findings, FMI, stated, “The burgeoning growth of the breast biopsy devices market signifies a pivotal shift in the healthcare landscape. With advancements in technology and increasing awareness, these devices play a crucial role in early detection and diagnosis, thereby improving patient outcomes.”
Key factors driving the market expansion include:
- Technological Advancements: Continuous innovation in biopsy devices, including needle design and imaging techniques, enhances accuracy and efficiency in breast cancer diagnosis.
- Rising Cancer Incidence: The growing prevalence of breast cancer globally propels the demand for biopsy devices, fostering early detection and timely intervention.
- Increasing Healthcare Expenditure: Higher healthcare expenditure, coupled with rising disposable incomes, fuels investment in advanced medical technologies, boosting market growth.
The burgeoning breast biopsy devices market offers lucrative opportunities for market players, including manufacturers, distributors, and healthcare providers, to capitalize on the escalating demand for innovative diagnostic solutions.
Breast Biopsy Devices Market: Competition Analysis
The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Breast Biopsy Devices market. Competitive information detailed in the Breast Biopsy Devices market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Breast Biopsy Devices market report.
Request Customization of the Report: https://www.futuremarketinsights.com/customization-available/rep-gb-1496
Key players covered in the report include:
- ARGON MEDICAL
- Becton Dickinson and Company
- C.R. Bard, Inc.
- Cook Medical Inc.
- Devicor Medical Products, Inc.
- F. Hoffmann-La Roche Ltd.,
- GE Healthcare
- Hologic, Inc.
- Leica Biosystems
- Medax Srl Unipersonale
- Planmed Oy,
- Scion Medical Technologies, LLC
- Siemens Healthier
Breast Biopsy Devices Market: Segmentation
Valuable information covered in the FMI’s Breast Biopsy Devices market report has been segregated into key segments and sub-segments.
By Product:
- Biopsy Needle
- Core Needles
- Fine Aspiration Needles
- MRI-Guide Biopsy Systems
- Ultrasound Guided Breast Biopsy Systems
- Two-Dimensional (2-D) Mammographic Ultrasonic Scanning Systems
- Three-Dimensional (3-D) B-Mode Mammographic Ultrasonic Scanning Systems
- Vacuum-Assisted Device (VAD)
- Guide Wire (Localization Wire)
- Breast Biopsy Marker
By Indication:
- Complex cyst
- Solid mass
- Suspicious solid mass( fibroadenoma )
- Suspicious micro calcifications
By End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
Get A Full Report: https://www.futuremarketinsights.com/checkout/1496
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube